|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| C07K 16/28 | |||
| A61K 39/00 | |||
| A61K 39/395 | |||
| A61K 9/00 | |||
| C07K 16/40 |
| (11) | Number of the document | 2992011 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14721295.5 |
| Date of filing the European patent application | 2014-04-25 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/058418 |
| Date | 2014-04-25 |
| (87) | Number | WO 2014/177461 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 13165741 | 2013-04-29 | EP | |
| 14151318 | 2014-01-15 | EP |
| (72) |
HARTMANN, Guido, DE
REGULA, Joerg Thomas, DE
RUETH, Matthias, DE
SCHAEFER, Wolfgang, DE
SCHLOTHAUER, Tilman, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES |
| FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES |